BC Week In Review | Jun 22, 2009
Clinical News

Alzheimer's biospectroscopy diagnostic: Pilot trial data

Data from a pilot trial published in the Journal of Alzheimer's Disease showed that Molecular Biometrics' Alzheimer's biospectroscopy diagnostic differentiated AD from healthy controls with a sensitivity of 80% and a specificity of 77%. The...
Items per page:
1 - 1 of 1